MidregiOn Proatrial Natriuretic Peptide to Guide SEconadry Stroke Prevention
Condition: Stroke, Ischemic Interventions: Drug: Rivaroxaban; Drug: Dabigatran; Drug: Apixaban; Drug: Edoxaban; Drug: Aspirin; Drug: Clopidogrel Sponsor: University of Zurich Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials